Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CD74 antibody

CD74 Reactivity: Human FACS Host: Mouse Monoclonal 11D59 unconjugated
Catalog No. ABIN2228590
  • Target See all CD74 Antibodies
    CD74 (HLA-DR-gamma (CD74))
    Reactivity
    • 184
    • 67
    • 13
    • 10
    Human
    Host
    • 121
    • 83
    • 3
    • 2
    • 1
    Mouse
    Clonality
    • 138
    • 70
    • 2
    Monoclonal
    Conjugate
    • 71
    • 16
    • 15
    • 9
    • 9
    • 7
    • 5
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    This CD74 antibody is un-conjugated
    Application
    • 123
    • 114
    • 78
    • 40
    • 35
    • 35
    • 29
    • 26
    • 16
    • 14
    • 13
    • 11
    • 9
    • 5
    • 2
    • 2
    • 2
    • 1
    • 1
    Flow Cytometry (FACS)
    Cross-Reactivity
    Human
    Cross-Reactivity (Details)
    Calculated cross reactivity: Hu
    Characteristics
    CD74 (HLA-DR, DHLAG, HLA class II histocompatibility antigen gamma, HLADG, Ia antigen-associated invariant chain, Ia-Gamma, Ii, p33, protein 41 antigen invariant chain)
    Purification
    Purified by Protein G affinity chromatography.
    Immunogen
    Recombinant corresponding to human CD74 expressed in CHO cells (NP_004346).
    Clone
    11D59
    Isotype
    IgG2b
    Top Product
    Discover our top product CD74 Primary Antibody
  • Application Notes
    Optimal working conditions should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Reconstitute with sterile PBS.
    Buffer
    Supplied as a lyophilized powder in PBS with 5 % trehalose.
    Storage
    -20 °C
    Storage Comment
    -20°C
  • Target
    CD74 (HLA-DR-gamma (CD74))
    Alternative Name
    CD74 (CD74 Products)
    NCBI Accession
    NP_004346
    Pathways
    Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Negative Regulation of intrinsic apoptotic Signaling, Cancer Immune Checkpoints
You are here:
Support